Federated Hermes, Inc. Collegium Pharmaceutical, Inc Transaction History

Federated Hermes, Inc.

$43.6 Billion
Q3 2024

A detailed history of Federated Hermes, Inc. transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Federated Hermes, Inc. holds 330,493 shares of COLL stock, worth $9.92 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

330,493

Previous 329,466 0.31%

Holding current value

$9.92 Million

Previous $10.6 Million 20.38%

% of portfolio

0.03%

Previous 0.03%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$31.4 - $39.07 $32,247 - $40,124	1,027 Added 0.31%	330,493 $12.8 Million
Q2 2024 Aug 08, 2024	SELL	$31.36 - $39.99 $2,038 - $2,599	-65 Reduced 0.02%	329,466 $10.6 Million
Q1 2024 May 14, 2024	BUY	$31.23 - $40.91 $3.65 Million - $4.78 Million	116,763 Added 54.88%	329,531 $12.8 Million
Q4 2023 Jan 31, 2024	BUY	$21.16 - $30.8 $1.94 Million - $2.83 Million	91,911 Added 76.05%	212,768 $6.55 Million
Q3 2023 Nov 13, 2023	BUY	$21.23 - $24.28 $391,990 - $448,305	18,464 Added 18.03%	120,857 $2.7 Million
Q2 2023 Aug 14, 2023	BUY	$21.06 - $24.0 $615,436 - $701,352	29,223 Added 39.94%	102,393 $2.2 Million
Q1 2023 May 08, 2023	BUY	$23.0 - $29.88 $1.68 Million - $2.19 Million	73,170 New	73,170 $1.76 Million
Q2 2022 Aug 15, 2022	SELL	$14.22 - $20.88 $3.73 Million - $5.47 Million	-262,095 Reduced 100.0%	9 $1,000
Q1 2022 May 13, 2022	SELL	$17.2 - $22.5 $3,990 - $5,220	-232 Reduced 0.09%	262,104 $5.34 Million
Q4 2021 Feb 14, 2022	BUY	$17.5 - $21.35 $1.22 Million - $1.49 Million	69,781 Added 36.24%	262,336 $4.9 Million
Q3 2021 Nov 15, 2021	BUY	$17.75 - $25.39 $371,880 - $531,945	20,951 Added 12.21%	192,555 $3.8 Million
Q2 2021 Aug 16, 2021	BUY	$21.74 - $25.28 $3.73 Million - $4.33 Million	171,379 Added 76168.44%	171,604 $4.06 Million
Q1 2021 May 13, 2021	SELL	$19.25 - $26.1 $73,650 - $99,858	-3,826 Reduced 94.45%	225 $5,000
Q4 2020 Feb 12, 2021	SELL	$17.83 - $22.29 $555,119 - $693,976	-31,134 Reduced 88.49%	4,051 $81,000
Q3 2020 Nov 12, 2020	SELL	$15.78 - $20.82 $1.47 Million - $1.94 Million	-93,017 Reduced 72.56%	35,185 $733,000
Q2 2020 Aug 13, 2020	SELL	$15.49 - $23.51 $2.02 Million - $3.06 Million	-130,270 Reduced 50.4%	128,202 $2.24 Million
Q1 2020 May 13, 2020	BUY	$13.89 - $25.45 $1.32 Million - $2.42 Million	95,210 Added 58.32%	258,472 $4.22 Million
Q4 2019 Feb 14, 2020	BUY	$10.7 - $22.24 $894,220 - $1.86 Million	83,572 Added 104.87%	163,262 $3.36 Million
Q3 2019 Nov 14, 2019	BUY	$10.16 - $13.28 $673,760 - $880,663	66,315 Added 495.81%	79,690 $915,000
Q2 2019 Aug 14, 2019	BUY	$10.62 - $16.59 $140,024 - $218,739	13,185 Added 6939.47%	13,375 $176,000
Q3 2018 Nov 13, 2018	SELL	$14.16 - $24.3 $424 - $729	-30 Reduced 13.64%	190 $3,000
Q2 2018 Aug 10, 2018	SELL	$21.79 - $28.29 $8,955 - $11,627	-411 Reduced 65.13%	220 $5,000
Q1 2018 May 09, 2018	SELL	$18.15 - $29.21 $2,323 - $3,738	-128 Reduced 16.86%	631 $16,000
Q4 2017 Feb 14, 2018	BUY	$9.3 - $19.14 $7,058 - $14,527	759	759 $0

Others Institutions Holding COLL

# of Institutions

256

Shares Held

38.6M

Call Options Held

100K

Put Options Held

21.1K

View Full List

About COLLEGIUM PHARMACEUTICAL, INC

Ticker COLL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 34,126,200
Market Cap $1.02B
Description
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...

More about COLL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Federated Hermes, Inc. with notifications on news.

Account

Federated Hermes, Inc. Collegium Pharmaceutical, Inc Transaction History